×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SHPH – shuttle pharmaceuticals holdings, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SHPH
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
10/29
09:09 pm
shph
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules [Yahoo! Finance]
Medium
Report
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules [Yahoo! Finance]
10/29
09:05 pm
shph
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
Medium
Report
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
10/29
04:05 pm
shph
Shuttle Pharma Pays Off Senior Secured Convertible Note
Medium
Report
Shuttle Pharma Pays Off Senior Secured Convertible Note
10/29
09:00 am
shph
Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
High
Report
Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
10/28
04:05 pm
shph
Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma
High
Report
Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma
10/28
09:00 am
shph
Shuttle Pharmaceuticals to Present at the 2024 ThinkEquity Conference on Wednesday, October 30, 2024
Medium
Report
Shuttle Pharmaceuticals to Present at the 2024 ThinkEquity Conference on Wednesday, October 30, 2024
9/16
09:00 am
shph
Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma
Low
Report
Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma
9/5
09:00 am
shph
Shuttle Pharma Announces Issuance of U.S. Patent for Selective Histone Deacetylase Inhibitors for the Treatment of Human Disease
High
Report
Shuttle Pharma Announces Issuance of U.S. Patent for Selective Histone Deacetylase Inhibitors for the Treatment of Human Disease
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/13
05:16 pm
shph
Form 8-K Shuttle Pharmaceuticals For: Nov 13
Medium
Report
Form 8-K Shuttle Pharmaceuticals For: Nov 13
11/1
06:03 am
shph
Form 8-K Shuttle Pharmaceuticals For: Oct 31
High
Report
Form 8-K Shuttle Pharmaceuticals For: Oct 31
10/31
12:06 pm
shph
Form 424B4 Shuttle Pharmaceuticals
Low
Report
Form 424B4 Shuttle Pharmaceuticals
10/30
06:03 am
shph
Form EFFECT Shuttle Pharmaceuticals
High
Report
Form EFFECT Shuttle Pharmaceuticals
10/29
09:00 am
shph
Form 8-K Shuttle Pharmaceuticals For: Oct 29
High
Report
Form 8-K Shuttle Pharmaceuticals For: Oct 29
10/28
04:05 pm
shph
Form 8-K Shuttle Pharmaceuticals For: Oct 28
High
Report
Form 8-K Shuttle Pharmaceuticals For: Oct 28
10/28
09:02 am
shph
Form 8-K Shuttle Pharmaceuticals For: Oct 28
Medium
Report
Form 8-K Shuttle Pharmaceuticals For: Oct 28
10/25
08:53 am
shph
Form 8-K Shuttle Pharmaceuticals For: Oct 21
Medium
Report
Form 8-K Shuttle Pharmaceuticals For: Oct 21
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: